Methylthioadenosine deaminase in an alternative quorum sensing pathway in Pseudomonas aeruginosa.
Rong Guan, Meng-Chiao Ho, Richard F G Fröhlich, Peter C Tyler, Steven C Almo, Vern L Schramm
Index: Biochemistry 51(45) , 9094-103, (2012)
Full Text: HTML
Abstract
Pseudomonas aeruginosa possesses an unusual pathway for 5'-methylthioadenosine (MTA) metabolism involving deamination to 5'-methylthioinosine (MTI) followed by N-ribosyl phosphorolysis to hypoxanthine and 5-methylthio-α-d-ribose 1-phosphate. The specific MTI phosphorylase of P. aeruginosa has been reported [Guan, R., Ho, M. C., Almo, S. C., and Schramm, V. L. (2011) Biochemistry 50, 1247-1254], and here we characterize MTA deaminase from P. aeruginosa (PaMTADA). Genomic analysis indicated the PA3170 locus to be a candidate for MTA deaminase (MTADA). Protein encoded by PA3170 was expressed and shown to deaminate MTA with 40-fold greater catalytic efficiency for MTA than for adenosine. The k(cat)/K(m) value of 1.6 × 10(7) M(-1) s(-1) for MTA is the highest catalytic efficiency known for an MTA deaminase. 5'-Methylthiocoformycin (MTCF) is a 4.8 pM transition state analogue for PaMTADA but causes no significant inhibition of human adenosine deaminase or MTA phosphorylase. MTCF is permeable to P. aeruginosa and exhibits an IC(50) of 3 nM on cellular PaMTADA activity. PaMTADA is the only activity in P. aeruginosa extracts to act on MTA. MTA and 5-methylthio-α-d-ribose are involved in quorum sensing pathways; thus, PaMTADA is a potential target for quorum sensing. The crystal structure of PaMTADA in complex with MTCF shows the transition state mimic 8(R)-hydroxyl group in contact with a catalytic site Zn(2+), the 5'-methylthio group in a hydrophobic pocket, and the transition state mimic of the diazepine ring in contact with a catalytic site Glu.
Related Compounds
Related Articles:
2015-04-21
[Proc. Natl. Acad. Sci. U. S. A. 112(16) , 5153-8, (2015)]
2014-12-01
[Laryngoscope 124(12) , 2750-6, (2014)]
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma.
2014-01-01
[Nat. Commun. 5 , 5712, (2014)]
Exometabolom analysis of breast cancer cell lines: Metabolic signature.
2015-01-01
[Sci. Rep. 5 , 13374, (2015)]
2015-05-01
[Ecotoxicology 24(4) , 779-94, (2015)]